Effects of COVID-19 Pandemic on the Outcomes of Colorectal Cancer
Sponsored by University of Bologna
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Any patient undergoing radical surgery for histologically confirmed diagnosis of cancer located in the colon, the rectum or the anus; or - any patient undergoing surgery with oncologic intents, for instance: radicalization of endoscopically removed cancerous polyp; radical surgery to remove large, at-risk polyp which are not removable by endoscopy; or - any patient undergoing planned or unpredicted palliative surgery for a primary cancer localized in the colon, rectum or anus; or - any patient undergoing a staging procedure (i.e. staging laparoscopy, surgical exploration), which did not result in any radical surgery due to advanced disease, metastasis, etc. and - age > 18 years - elective or urgent surgery
Exclusion Criteria
- Colorectal cancer recurring after previous surgery; - Cancer originating from other organs than the colon, the rectum and the anus; - Lack of significant histological details (expect when the cancer was not removed) - lack of 30-day follow-up